证券记录 · 已归档季度
ABT
Abbott Laboratories · Healthcare · Medical - Devices
22被追踪持有人
0Δ持有人
527.92M持有股份
$71.78B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +0.8% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 8.65M | $848.35M | n/a | n/a |
| Q2 2026 | 180 | 0 | 1.09B | $98.86B | +5 | −6 |
| Q1 2026 | 184 | +3 | 1.11B | $114.25B | +7 | −5 |
| Q4 2025 | 180 | +2 | 1.17B | $146.24B | +3 | n/a |
| Q3 2025 | 24 | 0 | 623.34M | $83.47B | +1 | −2 |
| Q2 2025 | 22 | 0 | 527.92M | $71.78B | +1 | −1 |
| Q1 2025 | 19 | 0 | 196.20M | $26.01B | +1 | −1 |
| Q4 2024 | 19 | -1 | 182.48M | $20.63B | n/a | −1 |
| Q3 2024 | 19 | 0 | 108.33M | $12.33B | +1 | −1 |
| Q2 2024 | 19 | n/a | 110.87M | $11.51B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 172.80M | n/a | $23.50B | 0.4% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 141.29M | n/a | $19.22B | 0.4% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (被动) | 78.35M | +0.9% | $10.66B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 38.29M | +3.8% | $5.18B | 0.4% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 25.05M | -15.8% | $3.41B | 0.6% | ▼ Trim | 5 | SEC ↗ ×8 |
| 6 | Norges Bank ✦ (被动) | 22.25M | +2.2% | $3.03B | 0.4% | ▲ Add | 5 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 13.56M | n/a | $1.84B | 0.1% | n/c | 1 | SEC ↗ ×7 |
| 8 | Fisher Asset Management ✦ | 11.86M | +1.8% | $1.61B | 0.6% | ▲ Add | 5 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 10.35M | +148.2% | $1.41B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Capital World Investors ✦ | 8.88M | -1.4% | $1.21B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 1.86M | +8.6% | $251.89M | 0.2% | ▲ Add | 5 | SEC ↗ ×7 |
| 12 | Adage Capital Partners ✦ | 1.60M | +12.7% | $217.31M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 875.49K | -0.8% | $119.08M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 509.56K | +134.2% | $69.31M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Millennium Management ✦ | 169.03K | -75.1% | $22.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 78.43K | +39.8% | $10.67M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 56.89K | -21.9% | $7.74M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 25.75K | -6.0% | $3.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 23.36K | +5.5% | $3.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Dodge & Cox ✦ | 17.32K | 0.0% | $2.36M | 0.0% | Held | 5 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 6.28K | -63.4% | $854,007 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Harris Associates (Oakmark) ✦ | 2.07K | 新增 | $281,677 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Harris Associates (Oakmark) | $281,677 | 0.0% |
已清仓
| Marshall Wace | $20.82M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 3,058 持有人, 1.35B 股份, $133.47B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
MCCOY JOHN A. JR.
Officer · 27 股 · $2,958
Aug 25
Ford Robert B
Officer, Director · 180.30K 股 · $20.95M
Aug 25
Ford Robert B
Officer, Director · 218.53K 股 · $25.26M
Aug 11
Morrone Louis H.
Officer · 5.85K 股 · $642,506
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据